Price: $468.00

Add to Cart:

  • Catalog #: SL100298
  • Unit Size: 2 x 25 ÁL (>10^9 TU/mL)

Please Choose:

LV-Synapsin-Cre; LV-Syn-Cre; LV-hSyn-Cre; Synapsin-Cre Lentivirus

Product Category: Pre-made recombinant lentivirus; LV-Synapsin-iCre; LV-Syn-iCre; LV-hSyn-iCre; Synapsin-iCre Lentivirus

Cre recombinase is a type I topoisomerase from bacteriophage P1 that catalyzes the site-specific recombination of DNA between loxP sites.  Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals.  By optimizing the mammalian codon usage for Cre recombinase, Cre expression is improved in the mammalian cells. This codon-improved Cre (known as iCre) transgene shows lower CpG content from the prokaryotic coding sequence, thus reducing the chances of epigenetic silencing in mammals.

LV-Synapsin-iCre is pre-made lentivirus which over-expresses iCre under human synapsin promoter for exclusive expression in CNS. Ready to use format.

Titer: > 1x109 TU/mL

Selection Antibiotic: No

Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection

Size: 2 x 25 µL (Std Pack)

Storage Buffer: PBS

Infection Protocol:

Transfer Vector Map:
LV-Synapsin-iCre; LV-Syn-iCre; LV-hSyn-iCre; Synapsin-iCre Lentivirus

Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm

Copyright © 2024 SignaGen Laboratories. All Rights Reserved.